Raymond James Maintains Outperform on Medtronic, Raises Price Target to $121

Raymond James maintains Medtronic (NYSE:MDT) with a Outperform and raises the price target from $118 to $121.

Benzinga · 11/20/2019 13:43

Raymond James maintains Medtronic (NYSE:MDT) with a Outperform and raises the price target from $118 to $121.